Kundan Minerals And Metals Ltd

Financial results

• Unaudited standalone and consolidated quarterly results for quarter ended 30 June 2026 approved, with Limited Review reports.

Independent director appointment

• Priya Khandelwal appointed as Additional Non-Executive Independent Director from 13 Aug 2026; five-year term, subject to shareholders' approval.

Strategic investments and consolidation

• Kundan Venture FZCO acquired 99% stake in West Africa Exploration & Mining; control achieved on 13 May 2026.
• Holding Company subscribed 70% equity in Kundan Venture FZCO in Feb 2025; AED 35,000 investment.

Regulatory and compliance updates

• DRI conducted a search; matter under review.
• Income Tax Department survey under Section 133A conducted Jan 28, 2026.
• Eastern Sugar & Industries Limited admitted to CIRP; NCLT approved the resolution plan.
• Trading approval for listing awaits from stock exchanges.
• Two subsidiaries’ interim results not reviewed; reliance on other auditors.

Meeting Details

• Date: 13 August 2026; Venue: Flat No. 4, Scindia House, Connaught Place, New Delhi.

Key Agenda Items

• Un-audited standalone and consolidated Q1 2026-27 results for quarter ended 30 June 2026.
• Any other business with the chair's permission.

Other Notes

• Trading window closed from 1 July 2026 until 48 hours after results are public.

Status

• No dematerialisation requests were confirmed during 01/04/2026 to 30/06/2026.

Resignation of Independent Director

• Resignation of Ms. Shefali Kesarwani (Independent Director) effective 01 July 2026 due to pre-occupation and personal commitments.
• She was not a member of any committee at the company.
• Ms. Shefali Kesarwani confirmed there are no material reasons beyond those stated.

Resigning director

• Ms. Shefali Kesarwani, Independent Director, resigns effective 01 July 2026.
• Reason: preoccupation with other activities.
• No other material reasons confirmed beyond the resignation letter.
• Was not a member of any company committees; no committee cessation.
• Directorships in other listed entities: Not Applicable.
• No regulatory or shareholder approval requirement mentioned.
• No immediate changes to board/committee composition reported.